Premium
cGMP regulates mechanosensitive TRPV4 channels in lung endothelial cells
Author(s) -
Yin Jun,
Wu Songwei,
Neye Nils,
Kuppe Hermann,
Kuebler Wolfgang M
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.1213.8
Subject(s) - mechanosensitive channels , trpv4 , sildenafil , chemistry , lung , in vivo , pulmonary edema , medicine , cgmp specific phosphodiesterase type 5 , vasodilation , transient receptor potential channel , biology , ion channel , receptor , microbiology and biotechnology
Previously, we and others have demonstrated that endothelial Ca 2+ influx via activated TRPV4 channels promotes hydrostatic edema formation. Here, we used real‐time microscopy and patch clamp analyses to study the regulation of this mechanosensitive channel by NO/cGMP pathway. In vivo, we tested the ability of sildenafil which prevents the degradation of cGMP by inhibition of phosphodiesterase 5 to attenuate hydrostatic edema in a rat model of left anterior descending coronary artery (LAD) occlusion. In isolated perfused rat lungs, elevation of left atrial pressure from 5 to 15 cmH 2 O induced an increase in endothelial Ca 2+ concentration ([Ca 2+ ] i ) from 105±6 to 173±10 nM. This [Ca 2+ ] i response was blocked by TRPV4 inhibitor ruthenium red (RuR; 1 μM), NO donor GSNO (250μM), or cGMP analog 8Br‐cGMP (100 μM) (n=5 each, p<0.05). Activation of TRPV4 by 4αPDD (10 μM) induced an [Ca 2+ ] i increase from 103±4 to 172±20 nM which was again blocked by RuR and 8Br‐cGMP (p<0.05). In pulmonary microvascular endothelial cells, 4αPDD activated an inward current that reversed near +20 mV and was blocked by 8Br‐cGMP. In vivo, sildenafil (1 mg/kg bw) reduced lung wet/dry weight ratio and improved arterial pO 2 after LAD occlusion. Our data demonstrate that cGMP attenuates Ca 2+ influx via TRPV4 in lung microvascular endothelial cells. This regulatory pathway may present a new therapeutic target for the treatment of hydrostatic lung edema.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom